Abstract: At least one isolated lactic acid bacteria strains selected from the following: TSP05 (Lactobacillus plantarum), TSF331 (Lactobacillus fermentum) and TSR332 (Lactobacillus reuteri) is provided. The above-mentioned active or inactive lactic acid bacteria strains have a function of hepatoprotection and is used in a form of a food composition or a pharmaceutical composition.

Abstract: A neutron capture therapy system capable of eliminating amyloid ?-protein includes a neutron capture therapy device and a compound capable of specifically binding to the amyloid ?-protein having a nuclide with a large thermal neutron capture cross section. The neutron capture therapy device includes a neutron source, a beam shaping assembly and a collimator, the neutrons released by the neutron source pass through the beam shaping assembly and are slowed into a neutron beam within a certain energy range. The neutron beam irradiates the compound, and the energy generated by the reaction thereof can destroy the structure of the amyloid ?-protein. The neutron capture therapy system can specifically eliminate the amyloid ?-protein, and reduce the damage to the tissues surrounding the amyloid ?-protein.

Abstract: A method for measuring radiation intensity includes measuring the radiation intensity received by the protein in a radiation field based on degree of protein degradation in the radiation field, wherein the degree of degradation is a ratio of the molecular weight of the protein before and after irradiation. The measuring method is simple in operation, small in number of steps, small in error, and capable of measuring radiation doses of various radiation fields or even mixed radiation fields. Use of a biological dosimeter for measuring the radiation intensity by the method in a neutron capture therapy system can not only assess radiation contamination in the irradiation chamber, but also evaluate the neutron dose.

Abstract: The present disclosure provides a neutron capture therapy system for eliminating amyloid ?-protein deposition plaque, comprising a neutron capture therapy device and a 10B-containing compound capable of specifically binding to amyloid ?-protein deposition plaque, and the energy generated when the neutron beam generated by the neutron capture therapy device irradiates on the 10B element can destroy the structure of the amyloid ?-protein deposition plaque. The beneficial effects of the present disclosure are targeted and highly effective destruction of amyloid ?-protein deposition plaque.

Abstract: A neutron capture therapy system capable of eliminating amyloid ?-protein includes a neutron capture therapy device and a compound capable of specifically binding to the amyloid ?-protein having a nuclide with a large thermal neutron capture cross section. The neutron capture therapy device includes a neutron source, a beam shaping assembly and a collimator, the neutrons released by the neutron source pass through the beam shaping assembly and are slowed into a neutron beam within a certain energy range. The neutron beam irradiates the compound, and the energy generated by the reaction thereof can destroy the structure of the amyloid ?-protein. The neutron capture therapy system can specifically eliminate the amyloid ?-protein, and reduce the damage to the tissues surrounding the amyloid ?-protein.